Picture1.jpg

DR. ANTOINE ESPINET

Founder and CEO

  • 2 years of experience in cell therapy startup

  • 4.5 years at McKinsey&Company as Engagement manager with experience in manufacturing, sourcing, strategy

  • PhD, Environmental Eng., Cornell University

  • Diplôme d’ingénieur, Ecole Centrale Paris

Cesare Cejas.jpg

DR. CESARE CEJAS

Founder, Head of Microfluidics

  • 5 years experience in microfabrication, microfluidic system design and engineering, prototyping and testing at the Microfluidics, MEMS, and Nanostructures Lab at Ecole Supérieure de Physique et Chimie Industrielle (ESPCI Paris)

  • PhD from Pierre et Marie Curie University in Materials Science (Physics and Chemistry)

  • Post-doctoral researcher for Sanofi (Pharmaceutical Sciences Dept. - Early Development)

James Kusena.jfif

DR. JAMES KUSENA

Head of Bioprocessing

  • Experience and PhD in human pluripotent stem cell culture and differentiation from Loughborough University.

  • Experience in cell therapy process development and manufacturing optimisation.

  • Background in Medicinal Chemistry, International Business and Health economics.

DR. VIJAY KUMAR

Microfluidics Engineer 

  • Experience and PhD in stem cell research and microfluidic bioprocessing.

  • Experience in computer aided design & manufacture, microfluidic device fabrication and finite element modelling.

  • Background in Biomedical Engineering.

NICHOLAS AKOSA

Bioprocessing Scientist

  • 3 years experience processing and analysing human cell populations for pharmacodynamic endpoints.

  • 2 years experience manufacturing CAR-T cells, including all stages of manufacturing - from starting cells to finished drug product for cancer immunotherapy trials.

  • Background in Biomedical Science. 

Jim Mills.png

DR. JIM MILLS

Bioprocessing expert

  • 20 years experience of working in the biopharma sector with expertise in all areas of bioprocess development; upstream process, downstream process and analytical development.

  • Ex-CEO of Cantab, ex-SVP Technical Operations at Abzena

Toby King.jpg

DR. TOBY KING

Chairman and interim COO

  • 25 years of experience in technology development, particularly in small organisations working in highly regulated environments, with several CTO/COO/CEO/Chairman roles

  • PhD in Mechanical Engineering applied to medical devices from Cambridge University

Michel Joie.jpg

MICHEL JOIE

System architect

  • 25+ years of experience in medical device design and development

  • 25+ years of project and multi disciplinary team management in small and large companies (Baxter, blood transfusion systems, Cardio Life Research, cardiac surgery acquired by St Jude Medical)

  • 8 years of consulting mostly for medtech start-ups (bariatric surgery, assisted reproductive treatment, hematology..)

Paul Simmons.jpg

DR. PAUL SIMMONS

Advisor

  • Head of Research and Product development at Mesoblast
    30+ years of experience in stem cell research

  • Past president of International Society of Stem Cell Research (ISSCR), C. Harold and Lorine G. Wallace Distinguished Univ.

  • Chair at the Univ. of Texas Health Institute, Inaugural Professor and Director, Centre for Stem Cell Research, Brown Foundation Institute of Molecular Medicine

Michael Spooner.jpg

MICHAEL SPOONER

Advisor

  • Non-executive director at Mesoblast since 2004

  • 15 years board experience for various Australian and international biotechnologies companies

  • Ex-PwC partner and director

PROF. TREVOR JONES

Advisor

  • Director of the drug discovery company, e-Therapeutics plc and the life science investment company Arix Bioscience Plc.

  • Boards as Director in the UK: NextPharma Ltd, ReNeuron,BAC BV, Sigma-Tau Finanziaria, Tecnogen SpA, SciClone Inc,and President of Sigma-Tau Pharmaceuticals Inc

  • Chair of the HEVER group

©2019 by MicrofluidX